1
Home
Companies

MedinCell

MedinCell
Leadership team

Mr. Christophe Douat (CEO & Chairman of Exec. Board)

Mr. Jaime Arango (CFO & Member of Exec. Board)

Dr. Joel Richard (Member of Exec. Board)

Products/ Services
Pharmaceutical
Number of Employees
100 - 500
Headquarters
Jacou, Languedoc-Roussillon, France
Established
2002
Revenue
5M - 20M
Traded as
EPA:MEDCL
Social Media
URL
https://www.medincell.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France.
History

MedinCell was founded in 2000 by a group of European scientists and clinicians, committed to create “smarter” medicines that would make a real difference in people’s life.

Mission
MedinCell’s mission is to develop and supply innovative drugs and drug delivery systems that will bring a functional solution to every patient.
Vision
MedinCell envisions a world in which all patients can benefit from better healthcare outcomes thanks to convenient, effective and safe delivery of medicines.
Key Team

Mr. Franck Pouzache (Chief People Officer)

Mr. David Heuze (Head of Communication & IR and Member of Exec. Board)

Mr. Adolfo Lopez Noriega (Head of Research & Member of Exec. Board)

Julie Alimi (Head of Legal)

Ms. Helen Martin (Head of Alliance Management)

Mr. Sebastien Enault (Chief Bus. Officer)

Ms. Quiterie De Beauregard (Head of Portfolio)

Recognition and Awards
MedinCell was awarded top prizes in the 2018 European Business Awards and were named by Gartner as a “Cool Vendor” in the healthcare market.
References

https://in.investing.com/equities/medincell-sa

https://finance.yahoo.com/quote/MEDCL.PA/profile?p=MEDCL.PA

https://www.crunchbase.com/organization/medincell

https://www.medincell.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

MedinCell
Leadership team

Mr. Christophe Douat (CEO & Chairman of Exec. Board)

Mr. Jaime Arango (CFO & Member of Exec. Board)

Dr. Joel Richard (Member of Exec. Board)

Products/ Services
Pharmaceutical
Number of Employees
100 - 500
Headquarters
Jacou, Languedoc-Roussillon, France
Established
2002
Revenue
5M - 20M
Traded as
EPA:MEDCL
Social Media
URL
https://www.medincell.com